214 related articles for article (PubMed ID: 21489997)
1. Met receptors induce Sam68-dependent cell migration by activation of alternate extracellular signal-regulated kinase family members.
Locatelli A; Lange CA
J Biol Chem; 2011 Jun; 286(24):21062-72. PubMed ID: 21489997
[TBL] [Abstract][Full Text] [Related]
2. Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells.
Castro NE; Lange CA
Breast Cancer Res; 2010; 12(4):R60. PubMed ID: 20687930
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of HGF/Met signaling to Brk and Sam68 in breast cancer progression.
Locatelli A; Lofgren KA; Daniel AR; Castro NE; Lange CA
Horm Cancer; 2012 Apr; 3(1-2):14-25. PubMed ID: 22124844
[TBL] [Abstract][Full Text] [Related]
4. Cardiotoxin III suppresses hepatocyte growth factor-stimulated migration and invasion of MDA-MB-231 cells.
Tsai PC; Chu CL; Chiu CC; Chang LS; Lin SR
Cell Biochem Funct; 2014 Aug; 32(6):485-95. PubMed ID: 24964901
[TBL] [Abstract][Full Text] [Related]
5. The transcriptional co-activator SND1 is a novel regulator of alternative splicing in prostate cancer cells.
Cappellari M; Bielli P; Paronetto MP; Ciccosanti F; Fimia GM; Saarikettu J; Silvennoinen O; Sette C
Oncogene; 2014 Jul; 33(29):3794-802. PubMed ID: 23995791
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Sam68 ribonucleoprotein complex regulated by epidermal growth factor.
Huot ME; Vogel G; Richard S
J Biol Chem; 2009 Nov; 284(46):31903-13. PubMed ID: 19762470
[TBL] [Abstract][Full Text] [Related]
7. SRC kinase activator CDCP1 promotes hepatocyte growth factor-induced cell migration/invasion of a subset of breast cancer cells.
Kawase N; Sugihara A; Kajiwara K; Hiroshima M; Akamatsu K; Nada S; Matsumoto K; Ueda M; Okada M
J Biol Chem; 2022 Mar; 298(3):101630. PubMed ID: 35085554
[TBL] [Abstract][Full Text] [Related]
8. Nuclear matrix-associated protein SMAR1 regulates alternative splicing via HDAC6-mediated deacetylation of Sam68.
Nakka KK; Chaudhary N; Joshi S; Bhat J; Singh K; Chatterjee S; Malhotra R; De A; Santra MK; Dilworth FJ; Chattopadhyay S
Proc Natl Acad Sci U S A; 2015 Jun; 112(26):E3374-83. PubMed ID: 26080397
[TBL] [Abstract][Full Text] [Related]
9. BMS-777607, a small-molecule met kinase inhibitor, suppresses hepatocyte growth factor-stimulated prostate cancer metastatic phenotype in vitro.
Dai Y; Siemann DW
Mol Cancer Ther; 2010 Jun; 9(6):1554-61. PubMed ID: 20515943
[TBL] [Abstract][Full Text] [Related]
10. The RNA-binding protein Sam68 regulates tumor cell viability and hepatic carcinogenesis by inhibiting the transcriptional activity of FOXOs.
Zhang T; Wan C; Shi W; Xu J; Fan H; Zhang S; Lin Z; Ni R; Zhang X
J Mol Histol; 2015 Dec; 46(6):485-97. PubMed ID: 26438629
[TBL] [Abstract][Full Text] [Related]
11. The RNA-binding and adaptor protein Sam68 modulates signal-dependent splicing and transcriptional activity of the androgen receptor.
Rajan P; Gaughan L; Dalgliesh C; El-Sherif A; Robson CN; Leung HY; Elliott DJ
J Pathol; 2008 May; 215(1):67-77. PubMed ID: 18273831
[TBL] [Abstract][Full Text] [Related]
12. Quercetin inhibits HGF/c-Met signaling and HGF-stimulated melanoma cell migration and invasion.
Cao HH; Cheng CY; Su T; Fu XQ; Guo H; Li T; Tse AK; Kwan HY; Yu H; Yu ZL
Mol Cancer; 2015 May; 14():103. PubMed ID: 25971889
[TBL] [Abstract][Full Text] [Related]
13. PKC mediates fluctuant ERK-paxillin signaling for hepatocyte growth factor-induced migration of hepatoma cell HepG2.
Hu CT; Cheng CC; Pan SM; Wu JR; Wu WS
Cell Signal; 2013 Jun; 25(6):1457-67. PubMed ID: 23524339
[TBL] [Abstract][Full Text] [Related]
14. Coupling of Grb2 to Gab1 mediates hepatocyte growth factor-induced high intensity ERK signal required for inhibition of HepG2 hepatoma cell proliferation.
Kondo A; Hirayama N; Sugito Y; Shono M; Tanaka T; Kitamura N
J Biol Chem; 2008 Jan; 283(3):1428-1436. PubMed ID: 18003605
[TBL] [Abstract][Full Text] [Related]
15. Signal-dependent regulation of splicing via phosphorylation of Sam68.
Matter N; Herrlich P; König H
Nature; 2002 Dec; 420(6916):691-5. PubMed ID: 12478298
[TBL] [Abstract][Full Text] [Related]
16. Nuclear localization of active HGF receptor Met in aggressive MDA-MB231 breast carcinoma cells.
Matteucci E; Bendinelli P; Desiderio MA
Carcinogenesis; 2009 Jun; 30(6):937-45. PubMed ID: 19357348
[TBL] [Abstract][Full Text] [Related]
17. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells.
Ye M; Hu D; Tu L; Zhou X; Lu F; Wen B; Wu W; Lin Y; Zhou Z; Qu J
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):497-504. PubMed ID: 18234991
[TBL] [Abstract][Full Text] [Related]
18. c-jun amino-terminal kinase and mitogen activated protein kinase 1/2 mediate hepatocyte growth factor-induced migration of brain endothelial cells.
Rush S; Khan G; Bamisaiye A; Bidwell P; Leaver HA; Rizzo MT
Exp Cell Res; 2007 Jan; 313(1):121-32. PubMed ID: 17055484
[TBL] [Abstract][Full Text] [Related]
19. The SPRY domain-containing SOCS box protein 1 (SSB-1) interacts with MET and enhances the hepatocyte growth factor-induced Erk-Elk-1-serum response element pathway.
Wang D; Li Z; Messing EM; Wu G
J Biol Chem; 2005 Apr; 280(16):16393-401. PubMed ID: 15713673
[TBL] [Abstract][Full Text] [Related]
20. Alternative splicing of the cyclin D1 proto-oncogene is regulated by the RNA-binding protein Sam68.
Paronetto MP; Cappellari M; Busà R; Pedrotti S; Vitali R; Comstock C; Hyslop T; Knudsen KE; Sette C
Cancer Res; 2010 Jan; 70(1):229-39. PubMed ID: 20028857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
